Effects of Commonly used Surfactants, Poloxamer 188 and Tween 80, on the Drug Transport Capacity of Intestinal Glucose Transporters
- PMID: 38997614
- DOI: 10.1208/s12249-024-02881-z
Effects of Commonly used Surfactants, Poloxamer 188 and Tween 80, on the Drug Transport Capacity of Intestinal Glucose Transporters
Abstract
Some glycoside drugs can be transported through intestinal glucose transporters (IGTs). The surfactants used in oral drug preparations can affect the function of transporter proteins. This study aimed to investigate the effect of commonly used surfactants, Poloxamer 188 and Tween 80, on the drug transport capacity of IGTs. Previous studies have shown that gastrodin is the optimal drug substrate for IGTs. Gastrodin was used as a probe drug to evaluate the effect of these two surfactants on intestinal absorption in SD rats through pharmacokinetic and in situ single-pass intestinal perfusion. Then, the effects of the two surfactants on the expression of glucose transporters and tight-junction proteins were examined using RT-PCR and western blotting. Additionally, the effect of surfactants on intestinal permeability was evaluated through hematoxylin-eosin staining. The results found that all experimental for Poloxamer 188 (0.5%, 2.0% and 8.0%) and Tween 80 (0.1% and 2.0%) were not significantly different from those of the blank group. However, the AUC(0-∞) of gastrodin increased by approximately 32% when 0.5% Tween 80 was used. The changes in IGT expression correlated with the intestinal absorption of gastrodin. A significant increase in the expression of IGTs was observed at 0.5% Tween 80. In conclusion, Poloxamer 188 had minimal effect on the drug transport capacity of IGTs within the recommended limits of use. However, the expression of IGTs increased in response to 0.5% Tween 80, which significantly enhanced the drug transport capacity of IGTs. However, 0.1% and 2.0% Tween 80 had no significant effect.
Keywords: glucose transporters; intestinal absorption; surfactants; transport capacity.
© 2024. The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists.
Similar articles
-
Strain differences in the drug transport capacity of intestinal glucose transporters in Sprague-Dawley versus Wistar rats, C57BL/6J versus Kunming mice.Int J Pharm. 2023 Jun 10;640:123000. doi: 10.1016/j.ijpharm.2023.123000. Epub 2023 Apr 30. Int J Pharm. 2023. PMID: 37254285
-
Effects of Three Kinds of Carbohydrate Pharmaceutical Excipients-Fructose, Lactose and Arabic Gum on Intestinal Absorption of Gastrodin through Glucose Transport Pathway in Rats.Pharm Res. 2024 Jun;41(6):1201-1216. doi: 10.1007/s11095-024-03720-3. Epub 2024 Jun 4. Pharm Res. 2024. PMID: 38834905
-
Role of glucose transporters in the intestinal absorption of gastrodin, a highly water-soluble drug with good oral bioavailability.J Drug Target. 2013 Jul;21(6):574-80. doi: 10.3109/1061186X.2013.778263. Epub 2013 Mar 12. J Drug Target. 2013. PMID: 23480725
-
Role of Glucose Transporters in Drug Membrane Transport.Curr Drug Metab. 2020;21(12):947-958. doi: 10.2174/1389200221666200810125924. Curr Drug Metab. 2020. PMID: 32778021 Review.
-
Nonionic surfactants modulate the transport activity of ATP-binding cassette (ABC) transporters and solute carriers (SLC): Relevance to oral drug absorption.Int J Pharm. 2019 Jul 20;566:410-433. doi: 10.1016/j.ijpharm.2019.05.033. Epub 2019 May 21. Int J Pharm. 2019. PMID: 31125713 Review.
References
-
- Gyimesi G, Pujol-Giménez J, Kanai Y, Hediger MA. Sodium-coupled glucose transport, the SLC5 family, and therapeutically relevant inhibitors: from molecular discovery to clinical application. Pflüg Arch - Eur J Physiol. 2020;472:1177–206. - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources